The platform functions as an extension of Dragon Copilot, which already automates the documentation of patient visits. By analyzing the conversation alongside a patient's medical history, current medications, payer rules, and social context, RhythmX Pulse generates immediate, evidence-based recommendations. These suggestions cover coding opportunities, care-gap alerts, and medication alternatives, which clinicians can review, edit, or dismiss before a patient leaves the exam room.
In section Releases
GW RhythmX Launches Precision Care AI on Microsoft Marketplace
Clinical AI firm GW RhythmX has integrated its RhythmX Pulse platform into the Microsoft Marketplace, allowing health systems to deploy personalized decision-support tools directly through existing Azure environments. The move aims to transition clinical AI from simple note-taking toward active, real-time guidance during patient encounters.
Deepthi Bathina, CEO and founder of GW RhythmX, emphasized that the technology moves beyond basic summarization to provide hyper-personalized clinical intelligence. For health systems already utilizing Dragon Copilot, the integration requires no separate implementation process. This launch marks the initial stage of a broader collaboration between the two companies, with plans to expand AI-driven support into pre-visit preparation and long-term patient management. To date, the platform has undergone more than 170,000 physician-reviewed clinical validations to ensure accuracy and safety in its automated recommendations.
Comments (0)
No comments yet. Be the first!